Sergey Brin and the 23andMe Story | Part 1
Infamous
00:00
The Conflict of Interest in Google's Investment in 23andMe
Google had invested $3.9 million in 23andMe, a DNA-testing company. Owen: Sergey Brin learned he carried a rare genetic mutation that put people at high risk for Parkinson's. The research suggested Sergey had between a 20 and 80% chance of developing Parkinson's. This is how Sergey's life-shattering news became a corporate talking point for 23andMe.
Transcript
Play full episode
